We are a leading genomic analysis company democratizing precision oncology, providing advanced molecular detection products that are accurate, actionable, easy to use and available worldwide.
Location: United States, Colorado, Boulder
Total raised: $150M
Investors 3
Funding Rounds 3
| Date | Series | Amount | Investors |
| 17.12.2019 | Series C | $55M | - |
| 15.05.2019 | Series B | $60M | - |
| 20.03.2018 | Series A | $35M | - |
Mentions in press and media 14
| Date | Title | Description |
| 19.12.2024 | Colorado BioScience Association: Life Sciences Ecosystem Raised $2.15 Billion This Year | The Colorado BioScience Association (CBSA) announced that the state’s life sciences ecosystem raised $2.15 billion in 2024, a 46% increase compared to 2023. Colorado – recognized as the Hub for Health Impact – has brought in nearly $12 bill... |
| 23.06.2020 | After filing for IPO, ArcherDX agrees to $1.4B buyout by Invitae | The companies said that combining together would enable cancer patients to access germline and somatic testing, liquid biopsy and tissue genomic profiling through a single platform in order to test for risk, therapy optimization and persona... |
| 08.06.2020 | Boulder’s ArcherDX files for $100M IPO as it plans to submit flagship test to FDA | BOULDER — ArcherDX Inc. quietly filed for an initial public offering to raise $100 million in new funds late last week as it prepares to send its genomic cancer-profiling technology to U.S. regulators later this year. The Boulder company’s ... |
| 17.12.2019 | ArcherDX Closes $55M Series C Financing | ArcherDX, Inc., a Boulder, Colo.-based molecular diagnostics company dedicated to developing solutions that advance the application of personalized genomic medicine, closed a $55m Series C financing. The round was led by Perceptive Advisors... |
| 17.12.2019 | Boulder Biotech Company Lands $55M for Personalized Genomic Medicine | Boulder's ArcherDX, a biotech company developing personalized genomic medicine, announced it closed a $55 million Series C round to grow its commercial footprint and further its product offerings. The round was led by Perceptive Advisors, w... |
| 16.05.2019 | Term Sheet — Thursday, May 16 | FORTUNE 500 DAY The Fortune 500 — Fortune’s annual list of the largest U.S. corporations ranked by total revenue — is out today. And here’s a fun fact: Just 500 companies produced enough revenue last year to equal two-thirds of the entire e... |
| 15.05.2019 | ArcherDX Closes Up To $60M Series B Financing | ArcherDX, Inc., a Boulder, Colo.-based molecular technology company dedicated to developing solutions that advance the application of personalized genomic medicine, closed an up to $60m Series B financing round. The round was led by Percept... |
| 15.05.2019 | ArcherDX raises $60M for personalized minimal residual disease diagnostics | ArcherDX has closed on a $60 million financing round to support its companion diagnostic program spanning solid and blood tumors, as well as circulating tumor DNA tests. Sponsored by Agilent Technologies How would you like to win free bench... |
| 15.05.2019 | ArcherDX raises $60M for personalized minimal residual disease diagnostics | ArcherDX has closed on a $60 million financing round to support its companion diagnostic program spanning solid and blood tumors, as well as circulating tumor DNA tests. The Boulder, Colorado-based company also plans to use the proceeds to ... |
| 22.03.2018 | Term Sheet — Thursday, March 22 | THE VC WAR CHEST Good morning, Term Sheet readers. Paid Content What you need to know about growing cyberattacks From ExtraHop Sequoia Capital is raising as much as $12 billion between its global growth fund and other venture capital and gr... |
Show more